We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,653.00
Bid: 1,654.00
Ask: 1,654.50
Change: 12.50 (0.76%)
Spread: 0.50 (0.03%)
Open: 1,638.50
High: 1,655.50
Low: 1,634.00
Prev. Close: 1,640.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-McDonald's, Apple, Model N, Neurocrine, HD Supply, AMD

Tue, 10th Sep 2013 12:29

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)

Sept. 10 (Reuters) - Some U.S. stocks to watch on Tuesday:

FUTURES CLIMB ON ROSY CHINA DATA, EASING SYRIA FEARS

U.S. stock index futures rose, putting the S&P 500 on trackfor a sixth day of gains, following another batch of rosyeconomic data out of China and as expectations eased about aWestern military strike against Syria. S&P 500 futures were up 0.65 percent, Dow Jones industrial average futures were up 0.62 percent, and Nasdaq 100 futures wereup 0.7 percent.

** APPLE INC, Monday close $506.17, up 0.5 pctpremarket

Apple is expected to introduce a cheaper version of theiPhone on Tuesday, bringing one of the industry's costliestsmartphones within reach of the masses in poorer emergingmarkets.

** MCDONALD'S CORP, Monday close $96.45, up 1 pctpremarket

The fast food chain reported a better-than-expected 1.9percent rise in global sales at established restaurants inAugust, boosted by stronger sales in Europe.

** ADVANCED MICRO DEVICES INC, Monday close $3.69,up 2 pct premarket

The chipmaker, targeting new markets as personal computersales decline, unveiled chips designed to run slot machines,factory robots, airport signs, medical equipment and otherdevices.

** MODEL N INC, Monday close $14.73, down 38 pctpremarket

The revenue management software maker forecast revenue forthe year ending September 2014 below analysts' estimates onMonday. Raymond James, Stifel Nicolaus and JPMorgan cut their ratings on the stock on Tuesday.

Analysts at Stifel said the company did not clearlyarticulate a plan to cut expenses. Raymond James analysts said areturn to revenue growth could be delayed well into 2015 unlessthe company quickly improved sales execution.

** NEUROCRINE BIOSCIENCES INC, Monday close $16.70,down 28 pct premarket

The company said on Monday that a lower dose of itsexperimental drug to treat a rare movement disorder did not meetthe main goal of a mid-stage clinical study. Cowen and Co cut its price target on the stock to $19 from $20while MKM Partners cut its target to $13.50 from $17.00 andOppenheimer to $15 from $19.

** HD SUPPLY HOLDINGS INC, Monday close $24.74, down9.5 pct premarket

The construction products supplier reported a widerquarterly loss for the second quarter due to expenses associatedwith debt restructuring. The company also forecast fiscal 2013results below analysts' estimates.

** STARWOOD PROPERTY TRUST INC, Monday close$25.04, down 4 pct premarket

The company, which finances and manages commercial mortgageloans, said it was offering 25 million shares in an underwrittenpublic offering.

** L&L ENERGY INC, Monday close $2.89, up 15 pctafter market

The coal miner's first-quarter profit more than doubled asproduction was boosted by the acquisition of two mines in Chinain November. Production rose 54 percent to 228,000 tons in thequarter.

** FIVE BELOW INC, Monday close $41.04, up 14 pctafter market

The specialty value retailer reported better-than-expectedresults for the second quarter due to a 6.6 percent increase insame-store sales. The company also raised its full-year earningsand revenue forecast.

** PVH CORP, Monday close $132.11, down 4.4 pctafter market

The maker of Calvin Klein and Tommy Hilfiger clothes gave athird-quarter sales and profit forecast that was below analysts'estimates. The company characterized the global environment as"challenging".

** BLACKBERRY LTD, Monday close $11.53, down 4 pctpremarket

The Canadian company's biggest shareholder has approachedseveral large Canadian investment funds about forging a deal totake the smartphone maker private, but the proposal is still "anairy-fairy, 'what if' kind of thing," according to a source withdirect knowledge of the situation.

** GLAXOSMITHKLINE PLC, Monday close $50.46, down 1pct premarket

The threat of generic copies of the company's best-sellinglung drug Advair finally making it to the market in the UnitedStates hit confidence in the drugmaker.

** MICROSOFT CORP, Monday close $31.65, up 1 pctpremarket

At least three of the top 20 investors in the company want aturnaround expert to succeed Steve Ballmer as chief executive.They have urged the technology giant's board to consider FordMotor Co Chief Executive Alan Mulally and ComputerSciences Corp Chief Executive Mike Lawrie for the job,several sources familiar with the matter said. (Compiled by Varun Aggarwal; Editing by Kirti Pandey)

More News
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.